|
| Press Releases |
|
 |
|
| Friday, August 8, 2025 |
|
|
云顶新耀耐赋康(R)扩产获批 亚洲全域完全批准双突破 加速迈向50亿销售峰值 |
| 近日，云顶新耀（HKEX: 1952.HK）宣布在扩产补充申请获国家药监局批准后，其旗下全球首个且唯一获得完全批准的IgA肾病对因治疗药物耐赋康(R)（布地奈德肠溶胶囊）又取得突破性进展。 more info >> |
|
| Tuesday, August 5, 2025 |
|
|
NEFECON(R) Receives NMPA Approval for Production Expansion in China, as Everest Medicines Accelerates Accessibility and Capacity Efforts |
| Everest Medicines (HKEX 1952.HK) today announced that the supplemental application for the production expansion of NEFECON has been officially approved by China's National Medical Products Administration (NMPA). more info >> |
|
|
全球首個IgA腎病對因治療藥物耐賦康®擴產獲批 雲頂新耀加速提升可及性與產能佈局 |
| 今日，雲頂新耀（HKEX: 1952.HK）宣布旗下中國首個且唯一獲得完全批准的IgA腎病對因治療藥物耐賦康®（布地奈德腸溶膠囊）擴產補充申請已正式獲得中國國家藥品監督管理局（NMPA）批准，標志著該產品在中國市場的供應能力將實現進一步提升。 more info >> |
|
|
全球首个IgA肾病对因治疗药物耐赋康®扩产获批 云顶新耀加速提升可及性与产能布局 |
| 今日，云顶新耀（HKEX: 1952.HK）宣布旗下中国首个且唯一获得完全批准的IgA肾病对因治疗药物耐赋康®（布地奈德肠溶胶囊）扩产补充申请已正式获得中国国家药品监督管理局（NMPA）批准，标志着该产品在中国市场的供应能力将实现进一步提升。 more info >> |
|
| Saturday, August 2, 2025 |
|
|
Everest Medicines Expands Strategic Investment in I-MAB to Advance the Global Value of Its Proprietary Next-Generation Cancer Immunotherapies |
| Everest Medicines (HKEX: 1952.HK) today announced a strategic equity investment in I-Mab (NASDAQ: IMAB), under which Everest will invest US$30.9 million (equivalent to approximately HK$242.6 million) in cash. more info >> |
|
| Friday, August 1, 2025 |
|
|
雲頂新耀宣佈增加對I-Mab的戰略投資 開發自研新一代腫瘤免疫療法的全球價值 |
| 2025年8月1日，雲頂新耀（股份代號：1952.HK）宣布進一步戰略增持I-Mab公司股份，將向I-Mab公司投資3,090萬美元（折合約2.426億港元）。 more info >> |
|
|
云顶新耀宣布增加对I-Mab的战略投资 开发自研新一代肿瘤免疫疗法的全球价值 |
| 2025年8月1日，云顶新耀（股份代号：1952.HK）宣布进一步战略增持I-Mab公司股份，将向I-Mab公司投资3,090万美元（折合约2.426亿港元）。 more info >> |
|
| Friday, July 25, 2025 |
|
|
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million |
| Everest Medicines (HKEX 1952.HK, Everest or the " Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a placing and subscription agreement with the placing agents and its controlling shareholder, CBC Group (the "Sellers"), for a top-up placement of 22,561,000 shares to raise approximately HK$1,572.50 million, representing approximately 6.87% of the total number of Shares in issue as at the date of this announcement, and approximately 6.45% of the total number of Shares in issue. more info >> |
|
|
雲頂新耀宣布配售股份 擬集資約15.725億港元 |
| 雲頂新耀有限公司（HKEX1952.HK）是一家專注於創新藥研發、臨床開發、制造和商業化的生物制藥公司，今日宣布以先舊後新配售22,561,000股，集資約15.725億港元，發行股份數占現有股本約6.87%, 占經擴大後的總股數約6.43%。 more info >> |
|
|
云顶新耀宣布配售股份 拟集资约15.725亿港元 |
| 云顶新耀有限公司（HKEX1952.HK）是一家专注于创新药研发、临床开发、制造和商业化的生物制药公司，今日宣布以先旧后新配售22,561,000股，集资约15.725亿港元，发行股份数占现有股本约6.87%, 占经扩大后的总股数约6.43%。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
西藏智汇矿业登陆港股：从高原走向国际 独特资源禀赋释放长期增长潜力
Dec 19, 2025 16:15 HKT/SGT
|
|
|
西藏智匯礦業登陸港股：從高原走向國際 獨特資源稟賦釋放長期增長潛力
Dec 19, 2025 15:35 HKT/SGT
|
|
|
A New Benchmark for Specialized Technology Stocks in Hong Kong! CiDi's Listing Marks a New Chapter in Commercial Intelligent Driving
Dec 19, 2025 11:30: JST
|
|
|
A New Benchmark for Specialized Technology Stocks in Hong Kong! CiDi's Listing Marks a New Chapter in Commercial Intelligent Driving
Dec 19, 2025 10:30 HKT/SGT
|
|
|
トヨタ、米国生産トヨタ車の26年からの日本導入を検討
Dec 19, 2025 10:00: JST
|
|
|
Air T, Inc. Announces Closing of Regional Express Acquisition
Dec 19, 2025 06:10 HKT/SGT
|
|
|
MHI Participates in Demonstration Testing of Vehicle-Infrastructure Integration System for Autonomous Buses in Shimotsuke City
Dec 19, 2025 3:24 JST
|
|
|
NEC and emaratech Collaborate on Biometric Smart Gates Supporting UAE Airport Operations
Dec 19, 2025 3:06 JST
|
|
|
Fujitsu to showcase mobility and physical AI tech at CES 2026
Dec 19, 2025 2:42 JST
|
|
|
Kirin and Fujitsu elucidate a novel gut-brain axis mechanism of citicoline for the first time worldwide through AI-based analysis and experimental validation leveraging drug discovery DX technology
Dec 19, 2025 2:06 JST
|
|
|
TANAKA PRECIOUS METAL GROUP and TANAKA MIRAI Lab. Released Their Fourth Collaborative Musical Work with Sound Wellness Lab (Della): "Precious Metal Orchestra - A Musical Voyage through the Sound of Precious Metals for Christmas" now available for streaming.
Dec 18, 2025 22:00 JST
|
|
|
Focus Graphite Announces Final Results From 2022 Drill Program at Lac Tetepisca; West Limb Extends Mineralized Strike to 8 KM
Dec 18, 2025 18:09 HKT/SGT
|
|
|
Spritzer MerryLand Returns This Year-End, Bringing Magical Festive Cheer to Taiping
Dec 18, 2025 17:44 HKT/SGT
|
|
|
臥安機器人今起招股 獲9家豪華基石陣容超7億港元認購 募集資金超10億港元
Dec 18, 2025 14:09 HKT/SGT
|
|
|
卧安机器人今起招股 获9家豪华基石阵容超7亿港元认购 募集资金超10亿港元
Dec 18, 2025 14:09 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
